T1	Drug_or_compound 0 3	GDP
T2	Drug_or_compound 8 11	AGE
T3	Multi-tissue_structure 37 47	peritoneal
T5	Multi-tissue_structure 135 154	peritoneal membrane
T6	Drug_or_compound 204 232	glucose degradation products
T7	Drug_or_compound 234 238	GDPs
T9	Drug_or_compound 354 358	GDPs
T10	Drug_or_compound 380 410	advanced glycation endproducts
T11	Drug_or_compound 412 416	AGEs
T12	Gene_or_gene_product 419 423	RAGE
T13	Drug_or_compound 502 506	AGEs
T14	Cell 527 544	mesothelial cells
T15	Drug_or_compound 592 596	GDPs
T16	Multi-tissue_structure 643 662	peritoneal membrane
T18	Gene_or_gene_product 668 672	RAGE
T19	Gene_or_gene_product 720 724	RAGE
T22	Multi-tissue_structure 824 843	peritoneal membrane
T23	Multi-tissue_structure 910 920	peritoneal
T24	Multi-tissue_structure 983 1002	peritoneal membrane
T25	Multi-tissue_structure 1006 1016	peritoneal
T26	Gene_or_gene_product 425 441	receptor for AGE
T1000	Organism 668 682	RAGE -/- mouse
T1001	Organism 1026 1034	patients
T21	Blood_vessel_development 787 802	neoangiogenesis
*	Equiv T6 T7
*	Equiv T10 T11
*	Equiv T26 T12
T4	Breakdown 48 54	damage
E1	Breakdown:T4 Theme:T3
T8	Remodeling 106 127	morphological changes
E2	Remodeling:T8 Theme:T5
T20	Positive_regulation 180 188	promoted
E3	Positive_regulation:T20 Theme:E2 Cause:T6
T27	Positive_regulation 359 366	promote
E4	Positive_regulation:T27 Theme:E5 Cause:T9
T28	Synthesis 367 376	formation
E5	Synthesis:T28 Theme:T10
T29	Gene_expression 514 523	expressed
E6	Gene_expression:T29 Theme:T12
T30	Remodeling 614 635	morphological changes
E7	Remodeling:T30 Theme:T16
T31	Breakdown 749 766	structural damage
E8	Breakdown:T31 Theme:T22
T32	Regulation 725 745	plays a pivotal role
E9	Regulation:T32 Cause:T19 Theme:E8
E10	Regulation:T32 Cause:T19 Theme:E11
E11	Blood_vessel_development:T21 AtLoc:T22
